Clinical Trial Update: A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

View source ↗

Summary

A standard-of-care study in adults with major depressive disorder has been terminated after inadequate response to an SSRI/SNRI antidepressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Status: TERMINATED